Gupta Bros Druggist Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 13 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 26.34%
- Profit Growth 79.64%
- Ebitda 103.38%
- Net Worth -60.09%
- Total Assets -10.21%
About Gupta Bros Druggist
Gupta Bros Druggist Private Limited (GBDPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 January 2012 and has a history of 13 years and one month. Its registered office is in New Delhi, Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Sunil Gupta, Deepanshu Gupta, and Sandeep Gupta serve as directors at the Company.
Company Details
- Location
New Delhi, Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U25190DL2012PTC229609
- Company No.
229609
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jan 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Gupta Bros Druggist?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Gupta  | Director | 03-Jan-2012 | Current |
| Deepanshu Gupta | Director | 08-Jan-2018 | Current |
| Sandeep Gupta | Director | 03-Jan-2012 | Current |
Financial Performance of Gupta Bros Druggist.
Gupta Bros Druggist Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 26.34% increase. The company also saw a substantial improvement in profitability, with a 79.64% increase in profit. The company's net worth observed a substantial decline by a decrease of 60.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gupta Bros Druggist?
In 2023, Gupta Bros Druggist had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Devsena Industries Private LimitedSunil Gupta, Deepanshu Gupta and 1 more are mutual person
- Brisc Healthcare Private Limited
Sandeep Gupta is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Gupta Bros Druggist?
Unlock and access historical data on people associated with Gupta Bros Druggist, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gupta Bros Druggist, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gupta Bros Druggist's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.